BIOTECHNOLOGY Archives | Pharma Tech Outlook

What 'Right to Try Act' Means for Pharma and Biotech Industries
Pharmatechoutlook >> news

A new law, the Right to Try Act is allowing terminally ill patients to try experimental therapies or drugs that are generally not approved by the Food and Drug Administration (FDA). The new law states that eligible patients can use the drugs that...

Being a Biotech CIO, or How to StopWorrying and Love Rapid Change
Pharmatechoutlook >> cioviewpoint

R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA

Biotechnology and biomedicine companies, by nature, experience explosive growth as scientific innovation feeds and fills their markets wif novel products and services. Supporting and building out teh technology infrastructure to support dis growth...

Rendering the Power of Integrated Biotechnology Services
Pharmatechoutlook >> cxoinsights

Tim Jackson, VP Technology, Advanced Clinical

If a firm is NOT using the cloud, they are missing important functional gains and substantial cost savings. The benefits of cloud computing are just as valuable for the life sciences/biotech industry as they are for other industries. Of course,...

The Magic Formula for Biotech IT
Pharmatechoutlook >> cioviewpoint

Jeffrey Keisling, CIO and SVP, Pfizer

With the explosive growth of genomics data and the broad implementation of electronic medical records, there are more opportunities than ever to leverage technology to better serve the needs of patients. Healthcare, our understanding of disease,...

Labcyte: Enhancing Biotech Experiments with Acoustics
Pharmatechoutlook >> vendor

Mark Fischer-Colbrie, President and CEO

Labcyte is revolutionizing liquid handling for life science research with the non-contact Echo liquid handling technology
Top 10 Analytics Solution Providers - 2019
Top 10 Analytics Consulting/Services Companies - 2019

Analytics SolutionSpecial